Press Release Virax Biolabs’ CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement Jul 16
Press Release Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds Jul 10
Press Release Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds Jul 9
Press Release Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics Jul 9